Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 2
1983 1
2008 1
2012 1
2013 1
2014 4
2015 3
2016 9
2017 2
2018 2
2019 6
2020 6
2021 7
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial.
Yahav D, Franceschini E, Koppel F, Turjeman A, Babich T, Bitterman R, Neuberger A, Ghanem-Zoubi N, Santoro A, Eliakim-Raz N, Pertzov B, Steinmetz T, Stern A, Dickstein Y, Maroun E, Zayyad H, Bishara J, Alon D, Edel Y, Goldberg E, Venturelli C, Mussini C, Leibovici L, Paul M; Bacteremia Duration Study Group. Yahav D, et al. Among authors: dickstein y. Clin Infect Dis. 2019 Sep 13;69(7):1091-1098. doi: 10.1093/cid/ciy1054. Clin Infect Dis. 2019. PMID: 30535100 Clinical Trial.
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.
Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD, Skiada A, Andini R, Eliakim-Raz N, Nutman A, Zusman O, Antoniadou A, Pafundi PC, Adler A, Dickstein Y, Pavleas I, Zampino R, Daitch V, Bitterman R, Zayyad H, Koppel F, Levi I, Babich T, Friberg LE, Mouton JW, Theuretzbacher U, Leibovici L. Paul M, et al. Among authors: dickstein y. Lancet Infect Dis. 2018 Apr;18(4):391-400. doi: 10.1016/S1473-3099(18)30099-9. Epub 2018 Feb 16. Lancet Infect Dis. 2018. PMID: 29456043 Clinical Trial.
Microbiota manipulation for weight change.
Dror T, Dickstein Y, Dubourg G, Paul M. Dror T, et al. Among authors: dickstein y. Microb Pathog. 2017 May;106:146-161. doi: 10.1016/j.micpath.2016.01.002. Epub 2016 Jan 12. Microb Pathog. 2017. PMID: 26792677 Review.
Reply to Wilson et al.
Dickstein Y, Leibovici L, Carmeli Y, Daikos G, Durante-Mangoni E, Friberg LE, Paul M. Dickstein Y, et al. Clin Infect Dis. 2020 Aug 22;71(5):1358-1359. doi: 10.1093/cid/ciz1100. Clin Infect Dis. 2020. PMID: 31734694 No abstract available.
Trends in antimicrobial resistance in Israel, 2014-2017.
Dickstein Y, Temkin E, Ish Shalom M, Schwartz D, Carmeli Y, Schwaber MJ. Dickstein Y, et al. Antimicrob Resist Infect Control. 2019 Jun 4;8:96. doi: 10.1186/s13756-019-0535-1. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 31171967 Free PMC article.
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii.
Kon H, Hameir A, Nutman A, Temkin E, Keren Paz A, Lellouche J, Schwartz D, Weiss DS, Kaye KS, Daikos GL, Skiada A, Durante-Mangoni E, Dishon Benattar Y, Yahav D, Daitch V, Bernardo M, Iossa D, Friberg LE, Theuretzbacher U, Leibovici L, Dickstein Y, Pollak D, Mendelsohn S, Paul M, Carmeli Y. Kon H, et al. Among authors: dickstein y. Microbiol Spectr. 2023 Jun 15;11(3):e0509322. doi: 10.1128/spectrum.05093-22. Epub 2023 May 23. Microbiol Spectr. 2023. PMID: 37219426 Free PMC article.
46 results